Beta Alethine in Treating Patients With Myeloma
Phase 1
- Conditions
- Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
- First Posted Date
- 2003-10-08
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- LifeTime Pharmaceuticals
- Registration Number
- NCT00006466
- Locations
- ๐บ๐ธ
Victory Over Cancer, Rockville, Maryland, United States
๐บ๐ธSt. Vincents Comprehensive Cancer Center, New York, New York, United States
๐บ๐ธEmory Clinic, Atlanta, Georgia, United States
Beta Alethine in Treating Patients With Low-Grade Lymphoma
Phase 1
- Conditions
- Lymphoma
- First Posted Date
- 2003-10-08
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- LifeTime Pharmaceuticals
- Registration Number
- NCT00007839
- Locations
- ๐บ๐ธ
Victory Over Cancer, Rockville, Maryland, United States
Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
Phase 1
- Conditions
- Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- LifeTime Pharmaceuticals
- Registration Number
- NCT00041379
- Locations
- ๐บ๐ธ
Victory Over Cancer, Rockville, Maryland, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath